Pathogenicity and immunogenicity of recombinant methyltransferase-defective vesicular stomatitis virus
To prevent the vesicular stomatitis virus (VSV) disease, using a panel of recombinant VSV (E1764A, S1827A, Y1650A, and F1691A) that were defective in mRNA cap methylation as vaccine to inoculate five-week-old BALB/c female mice through oral route with 1×10<sup>6</sup> PFU, the pathogenic...
Saved in:
| Main Authors: | ZHANG Xiao-dong, SUN Jing, LI Jian-rong, YU Lian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zhejiang University Press
2011-07-01
|
| Series: | 浙江大学学报. 农业与生命科学版 |
| Subjects: | |
| Online Access: | https://www.academax.com/doi/10.3785/j.issn.1008-9209.2011.04.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
DIRECTED EVOLUTION OF AN ONCOLYTIC VESICULAR STOMATITIS VIRUS ADAPTED TO HUMAN MALIGNANT MENINGIOMA CELLS
by: Burak Gizem Göleş, et al.
Published: (2024-02-01) -
Oncolytic Vesicular Stomatitis Virus: Optimisation Strategies for Anti-Cancer Therapies
by: Margarita Zinovieva, et al.
Published: (2024-10-01) -
Vesicular Stomatitis Virus Transmission Dynamics Within Its Endemic Range in Chiapas, Mexico
by: Lawrence H. Zhou, et al.
Published: (2024-11-01) -
Assessment of Single‐Cycle M‐Protein Mutated Vesicular Stomatitis Virus as a Safe and Immunogenic Mucosal Vaccine Platform for SARS‐CoV‐2 Immunogen Delivery
by: En Zhang, et al.
Published: (2024-12-01) -
Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development
by: Mohamed Mustaf Ahmed, et al.
Published: (2024-12-01)